Sign Up to like & get
recommendations!
1
Published in 2019 at "Psychopharmacology"
DOI: 10.1007/s00213-019-05387-w
Abstract: F17464, a dopamine D3 receptor antagonist with relatively high D3 selectivity (70 fold vs D2 in vitro), exhibits an antipsychotic profile in preclinical studies, and therapeutic efficacy was demonstrated in a randomized placebo-controlled clinical trial…
read more here.
Keywords:
receptor occupancy;
study healthy;
11c phno;
f17464 dopamine ... See more keywords